Connected polymeric drug delivery systems: A promise for the future!
Vol 6, Issue 1, 2023
VIEWS - 386 (Abstract) 0 (Untitled) 28 (PDF)
Abstract
Subcutaneous (SC) drug delivery is one of the best routes of drug administration to patients over intravenous (IV) administration, due to the ease of application and patient acceptance. The main limitation of using SC route is administering larger volumes of drug, greater than 3–5 mL for therapeutic dosages. The wearable injectors, on body devices is an attractive option for larger volume drug delivery to patients. Thus, the need for self-administration strategy at the safety of home is growing faster, and is required for the next level of time-dependent and high-volume drug delivery. The advances for low cost, connected on-body delivery systems hold great opportunity for the novel ways of delivering home based drug therapy, in the future to come.
Keywords
References
1. Fazal T, Murtaza BN, Shah M, et al. Recent developments in natural biopolymer-based drug delivery systems. RSC Adv 2023; 13(33): 23087–23121. doi: 10.1039/d3ra03369d
2. Amjadi M, Sheykhansari S, Nelson BJ, Sitti M. Recent Advances in Wearable Transdermal Delivery Systems. Advanced Materials 2018; 30(7). doi: 10.1002/adma.201704530
3. Chandy T. Biocompatibility of materials and its relevance to drug delivery and tissue engineering. In: Biointegration of Medical Implant Materials. Elsevier; 2020. pp. 297–331. doi: 10.1016/b978-0-08-102680-9.00012-3
4. Chandy T, Rao GHR, Wilson RF, Das GS. Development of Poly (Lactic Acid)/Chitosan Co-Matrix Microspheres: Controlled Release of Taxol-Heparin for Preventing Restenosis. Drug Delivery 2001; 8(2): 77–86. doi: 10.1080/107175401750177025
5. Chandy T, Das GS, Wilson RF, Rao GHR. Development of polylactide microspheres for protein encapsulation and delivery. J of Applied Polymer Sci 2002; 86(5): 1285–1295. doi: 10.1002/app.11139
6. Simpson I, Bhandari V. Considering the Sustainability Impact of Connected Inhalers in the Treatment of Asthma. ONdrugDelivery; 2022. pp. 42–48.
7. Simpson I. How Connectivity Adds Value to Injectable Drug Delivery Devices. ONdrugDelivery; 2019. pp. 60–64.
DOI: https://doi.org/10.24294/jpse.v6i1.2901
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Thomas Chandy
License URL: https://creativecommons.org/licenses/by-nc/4.0/
This site is licensed under a Creative Commons Attribution 4.0 International License.